TrialThe patient2025

Exit Interviews Examining Changes to Mood and Work/Productivity Impacts Related to Vasomotor Symptoms: Perspectives of Postmenopausal Women Receiving Elinzanetant in Phase III Clinical Trials.

Claudia Haberland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.